Topographical distribution of neurochemical changes in Alzheimer's disease

https://doi.org/10.1016/0022-510X(88)90118-9Get rights and content

Abstract

Biochemical indices of cortical nerve cells affected in Alzheimer's disease have been proposed (excitatory dicarboxylic amino acid, EDAA, sodium-dependent carrier; phosphate-activated glutaminase activity; serotonin type 2 recognition site; somatostatin-like immunoreactivity). These and the content of EDAAs and two related amino acids, and choline acetyltransferase (ChAT) activity have been measured in up to 13 areas of cerebral cortex and the cerebellar cortex from 16 patients with Alzheimer's disease and 17 controls. Reduction of the index of the serotonin recognition site, somatostatin content and another biochemical index of interneurones coincide and indicate a rather unexpected focal loss of such neurones from the parietal lobe. No unequivocal measure of the integrity of pyramidal neurones could be established as the content of no amino acid was reduced, the index of the EDAA carrier showed evidence of change in few brain regions and glutaminase activity was subject to unexplained variability. ChAT activity alone closely paralleled a previous report of the distribution of morphological degeneration. The results are discussed in relation to therapy and positron emission tomography.

References (53)

  • A. Schotte et al.

    Characterisation and regional distribution of serotonin S2 receptors in human brain

    Brain Res.

    (1983)
  • C.C.T. Smith et al.

    The evoked release of endogenous amino acids from tissue prisms of human neocortex

    Brain Res.

    (1983)
  • C.C.T. Smith et al.

    Amino acid release from biopsy samples of temporal neocortex from patients with Alzheimer's disease

    Brain Res.

    (1983)
  • S.R. Vincent et al.

    A comparison of sodium-dependent glutamate binding with high-affinity glutamate uptake in rat striatum

    Brain Res.

    (1980)
  • G.L. Wenk et al.

    [3H]ketanserin binding increases in monkey cortex following basal forebrain lesions with lbotenic acid

    Neurochem. Int.

    (1986)
  • R.J. Wenthold et al.

    Immunocytochemical localization of aspartate aminotransferase and glutaminase immunoreactivites in the cerebellum

    Brain Res.

    (1986)
  • G.K. Wilcock et al.

    Plaques, tangles and dementia

    A quantitative study

    J. Neurol. Sci.

    (1982)
  • M.F. Beal et al.

    Widespread reduction of somatostatin-like immunoreactivity in the cerebral cortex in Alzheimer's disease

    Ann. Neurol.

    (1986)
  • D.M. Bowen

    Biochemical assessment of neurotransmitter and metabolic dysfunction and cerebral atrophy in Alzheimer's disease

  • D.M. Bowen et al.

    Biochemical assessment of serotonergic and cholinergic dysfunction and cerebral atrophy in Alzheimer's disease

    J. Neurochem.

    (1983)
  • D.M. Bowen et al.

    Neurotransmitter and metabolic dysfunction in Alzheimer's dementia: Relationship to histopathological features

  • N.G. Bowery et al.

    (-)-Baclofen decreases neurotransmitter release in the mammalian CNS by an action at a novel GABA receptor

    Nature

    (1980)
  • A. Brun

    An overview of light and electron microscopic changes

  • J.B. Chawluk et al.

    Positron emission tomography in aging and dementia: effect of cerebral atrophy

    J. Nucl. Med.

    (1987)
  • A.J. Cross et al.

    Serotonin receptor changes in dementia of the Alzheimer's type

    J. Neurochem.

    (1984)
  • A.J. Cross et al.

    The selectivity of the reduction of serotonin S2 receptors in Alzheimer-type dementia

    Neurobiol. Aging

    (1986)
  • Cited by (128)

    • Pattern of tau hyperphosphorylation and neurotransmitter markers in the brainstem of senescent tau filament forming transgenic mice

      2013, Brain Research
      Citation Excerpt :

      Particularly the cholinergic basal nucleus of Meynert and septal nuclei with projections to almost all cortical areas, the hippocampus and the thalamus are severely impaired in a subset of AD brains (Herholz, 2008; McGeer et al., 1984). The loss and functional disturbance of cholinergic forebrain neurons is associated with a reduction of cholinergic neurotransmission, choline acetyltransferase and acetylcholinesterase enzyme activity (Francis et al., 1999; Herholz, 2008; Procter et al., 1988). Likewise, the content of the catecholamine noradrenaline is reduced in AD temporal and frontal cortices (Palmer and DeKosky, 1993).

    • The serotonergic system in ageing and Alzheimer's disease

      2012, Progress in Neurobiology
      Citation Excerpt :

      The use of 5-HT1A receptor antagonists has given promising results in preclinical studies in rodents and non-human primates, as well as in the clinical trials of AD patients (Hirst et al., 2008; Luttgen et al., 2005a; Madjid et al., 2006; Millan et al., 2004; Misane and Ogren, 2003). Autoradiographic binding studies using 5-HT2A receptor antagonist [3H]-ketanserin have consistently demonstrated reductions in 5-HT2A receptor density in the temporal, frontal and parietal cortex as well as amygdala, entorhinal cortex and in the hippocampus of post-mortem AD brains (Table 7) (Cheng et al., 1991; Cross et al., 1986; Crow et al., 1984; Dewar et al., 1990; Procter et al., 1988). Reduced 5-HT2A receptor density has been further confirmed by PET (Blin et al., 1993; Marner et al., 2010a; Meltzer et al., 1999; Santhosh et al., 2009), SPECT (Versijpt et al., 2003) and magnetic resonance imaging (MRI) (Hasselbalch et al., 2008).

    • Revisiting the cholinergic hypothesis of behavioral and psychological symptoms in dementia of the Alzheimer's type

      2011, Ageing Research Reviews
      Citation Excerpt :

      Psychosis frequently occurs subsequent to the onset of dementia. Published prevalence estimates of psychosis in patients with AD range from 10% to 73% with an overall median of 34% within clinic populations, and from 7% to 20% in community and clinical trials populations depending on definitions used (Procter et al., 1988). Neuroimaging, pharmacological and biochemical observations imply that cholinergic deficiency has a role in the development of psychosis.

    • Krill phosphatidylserine improves learning and memory in Morris water maze in aged rats

      2010, Progress in Neuro-Psychopharmacology and Biological Psychiatry
    View all citing articles on Scopus
    View full text